Amgen, AbbVie 'ahead of the crowd' in fighting payers' latest assault on copay coupons

Copay coupons save patients money and help drugmakers steer scripts toward newer products or older ones facing new rivals. But because pharma does the steering, often toward drugs that actually cost more, payers hate them.